Journal for ImmunoTherapy of Cancer (Feb 2022)

CD8+PD-1+ to CD4+PD-1+ ratio (PERLS) is associated with prognosis of patients with advanced NSCLC treated with PD-(L)1 blockers

  • Francois-Xavier Danlos,
  • Aurélien Marabelle,
  • Roberto Ferrara,
  • Benjamin Besse,
  • Lydie Cassard,
  • Nathalie Chaput,
  • Aude Desnoyer,
  • Boris Duchemann,
  • Marie Naigeon,
  • Edouard Auclin,
  • Jean-Mehdi Jouniaux,
  • Lisa Boselli,
  • Jonathan Grivel,
  • Laura Mezquita,
  • Caroline Caramella

DOI
https://doi.org/10.1136/jitc-2021-004012
Journal volume & issue
Vol. 10, no. 2

Abstract

Read online

No abstracts available.